[go: up one dir, main page]

AR076856A1 - Lenalidomida polimorfa y proceso para su preparacion - Google Patents

Lenalidomida polimorfa y proceso para su preparacion

Info

Publication number
AR076856A1
AR076856A1 ARP100101577A ARP100101577A AR076856A1 AR 076856 A1 AR076856 A1 AR 076856A1 AR P100101577 A ARP100101577 A AR P100101577A AR P100101577 A ARP100101577 A AR P100101577A AR 076856 A1 AR076856 A1 AR 076856A1
Authority
AR
Argentina
Prior art keywords
preparation
lenalidomide
polymorph
crystalline
theta
Prior art date
Application number
ARP100101577A
Other languages
English (en)
Inventor
Srinivasulu Rangineni
Shakti Singh
Vamsi Krishna Muppidi
Original Assignee
Reddys Lab Ltd Dr
Reddys Lab Inc Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reddys Lab Ltd Dr, Reddys Lab Inc Dr filed Critical Reddys Lab Ltd Dr
Publication of AR076856A1 publication Critical patent/AR076856A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente solicitud se relaciona con una forma cristalina de la lenalidomida, procesos para su preparacion, y el uso de la forma polimorfica en la preparacion de composiciones farmacéuticas. Reivindicacion 1: Lenalidomida cristalina con un patron de difraccion de rayos-x en polvo que comprende uno o más picos localizados en las posiciones 8,29; 25,9 y 27,5 0,2 grados 2-theta.
ARP100101577A 2009-05-08 2010-05-07 Lenalidomida polimorfa y proceso para su preparacion AR076856A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1079CH2009 2009-05-08
US22652409P 2009-07-17 2009-07-17

Publications (1)

Publication Number Publication Date
AR076856A1 true AR076856A1 (es) 2011-07-13

Family

ID=43050836

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP100101577A AR076856A1 (es) 2009-05-08 2010-05-07 Lenalidomida polimorfa y proceso para su preparacion

Country Status (2)

Country Link
AR (1) AR076856A1 (es)
WO (1) WO2010129636A2 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA83504C2 (en) 2003-09-04 2008-07-25 Селджин Корпорейшн Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
TWI475014B (zh) * 2009-09-17 2015-03-01 Scinopharm Taiwan Ltd 固體形態的３－（４－胺基－１－側氧基－１，３－二氫－異吲哚－２－基）－哌啶－２，６－二酮及其製造方法
WO2011061611A1 (en) * 2009-11-19 2011-05-26 Ranbaxy Laboratories Limited Process for the preparation of form b of lenalidomide
WO2012127493A1 (en) 2011-03-23 2012-09-27 Hetero Research Foundation Polymorphs of lenalidomide
WO2016024286A2 (en) * 2014-08-11 2016-02-18 Avra Laboratories Pvt. Ltd. An improved process for synthesis of lenalidomide
EP3135275B1 (en) * 2015-08-27 2020-05-13 Grindeks, A Joint Stock Company Pharmaceutical composition capable of the incorporation of lenalidomide in various crystalline modifications
TWI664172B (zh) * 2016-08-25 2019-07-01 大陸商浙江海正藥業股份有限公司 來那度胺的晶型及其製備方法和用途
CN112999224B (zh) * 2021-03-03 2022-09-16 天津大学 一种布洛芬载来那度胺复合颗粒及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5635517B1 (en) * 1996-07-24 1999-06-29 Celgene Corp Method of reducing TNFalpha levels with amino substituted 2-(2,6-dioxopiperidin-3-YL)-1-oxo-and 1,3-dioxoisoindolines
UA83504C2 (en) * 2003-09-04 2008-07-25 Селджин Корпорейшн Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione

Also Published As

Publication number Publication date
WO2010129636A2 (en) 2010-11-11
WO2010129636A3 (en) 2011-03-31

Similar Documents

Publication Publication Date Title
AR076856A1 (es) Lenalidomida polimorfa y proceso para su preparacion
MX355428B (es) Formas cristalinas del acido [ (4-hidroxi-1-metil-7-fenoxi-isoquin olin-3-carbonil) -amino] -acetico inhibidor de prolil hidroxilasa.
BRPI1013426A2 (pt) organismos para produção de 1,3-butanodiol
BRPI0911024A2 (pt) "método para produzir macarrão instantâneo"
GT201200250A (es) Ariltriazolonas ligadas a bisarilo y su uso
AR096046A1 (es) Derivados de 2,2-difluoropropanamida de metil bardoxolona, formas polimórficas y métodos de uso
SV2011004019A (es) 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso
MY162411A (en) Crystalline forms of a macrolide, and uses therefor
BRPI0817154A2 (pt) "método de modificar uma célula de levedura para a produção de etanol, célula de levedura modificada, uso de uma célula de levedura modificada e método para a produção de etanol"
AR077203A1 (es) Forma polimorfica d del acetato de bazedoxifeno, composiciones farmaceuticas que la contienen metodo para prepararla y uso del mismo para tratar enfermedades mediadas por moduladores selectivos de receptores estrogenicos (serms)
ES2421956B1 (es) Nueva forma cristalina de sulfato de sitagliptina
IL204658A (en) Pharmaceutical preparation for topical use in the form of an opaque gel-gel containing diclofenac diethylammonium salt
AR061311A1 (es) Procesos para preparar clorhidrato de cinacalcet y formas polimorficas del mismo
PL2220152T3 (pl) Sposób otrzymywania kompozycji sieciującej
BRPI0823256A2 (pt) Uso de sacarose como substrato para produção fermentativa de 1,2-propanodiol
IL210134A0 (en) Topical composition for the treatment of actinic keratosis
ECSP13012575A (es) Monohidrato de derivados de aza-adamantano
BRPI0814261A2 (pt) Micor-organismos termofílicos para produção de etanol
EP2149379A4 (en) USE OF A COMPOUND ACTIVE COMPOSITION IN THE PREPARATION OF A PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF PORTAL HYPERTENSION OCCURRED BY LIVER CROP
AR075418A1 (es) Polimorfo cristalino de 3-{[5-(azetidin-1-ilcarbonil)pirazin-2-il]oxi}-5-{[(1s)-1-metil-2-(metiloxi)etil]oxi}-n-(5-metilpirazin-2-il)benzamida,composiciones farmaceuticas que los contienen, proceso para prepararla y uso de las mismas para el tratamiento de la diabetes tipo ii y/u obesidad.
BRPI0811548A2 (pt) Forma polimórfica de um composto, composição farmacêutica, e, processo para sintetizar uma forma polimórfica de um composto
CR7876A (es) Forma cristalina alfa del ranelato de estroncio, procedimiento para su preparacion y composiciones farmaceuticas que la contienen
AR085543A1 (es) Agomelatina, una forma cristalina vii, sus metodos de preparacion, aplicaciones y composiciones farmaceuticas
FI20070134A0 (fi) Menetelmä pelkistysainekoostumuksen valmistamiseksi
AR082435A1 (es) Valsartan altamente cristalino

Legal Events

Date Code Title Description
FB Suspension of granting procedure